Jonathan Zurawski

10PUBLICATIONS
28CO-AUTHORS
Medical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Gene and molecular therapyPsychosocial aspects of childbirth and perinatal mental healthMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 13, 2026
ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: A human and experimental study.

Jonathan Zurawski, Alara Tuncer, Martin R Profant

|Jul 14, 2025
Nasal foralumab treatment of PIRA induces regulatory immunity, dampens microglial activation and stabilizes clinical progression in non-active secondary progressive MS.

Tanuja Chitnis, Tarun Singhal, Jonathan Zurawski

|Apr 28, 2025
Change in serum neurofilament light chain and glial fibrillary acidic protein levels with high-efficacy and low-efficacy early therapy in multiple sclerosis.

Evan Madill, Vanessa Moreira Ferreira, Brian Healy

|Mar 19, 2025
Cladribine Is Associated With Stable Cortical Gray Matter Lesion Burden in Multiple Sclerosis: A 7T MRI Study.

Jonathan Zurawski, Shahamat Tauhid, Brian C Healy

|Jan 15, 2025
A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MS.

Maria K Houtchens, Maria Claudia Manieri, Tatenda Dawn Mahlanza

|Apr 14, 2023
Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccine.

Sarah Conway, Shrishti Saxena, Clare Baecher-Allan

Pageof 2